NCT03990064

Brief Summary

PTSD is a debilitating mental disorder that may develop after experiencing or witnessing a life-threatening event. With appropriate care, treatment efficiency is variable and around 20% of the patients do not respond to psychological treatment. Complementary treatments are needed. as PTSD implied autonomic nervous system (ANS) dysfonction, complementary treatment focusing on ANS regulation, as welle as musicotherapy, may have an interest.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 18, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

February 1, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

August 4, 2022

Status Verified

August 1, 2022

Enrollment Period

Same day

First QC Date

May 8, 2019

Last Update Submit

August 2, 2022

Conditions

Keywords

effective connectomic neurological soft signs

Outcome Measures

Primary Outcomes (1)

  • change in PTSD symptoms

    questionnaire Posttraumatic CheckList 5 (PCL5; threshold =33)

    change from PTSD symptoms at two months and at six months

Secondary Outcomes (4)

  • change in neurological soft signs

    change from neurological soft signs at two months and at six months

  • change in effective connectomic

    change from effective connectomic at two months and at six months

  • Autonomous nervous system regulation

    change from Autonomous nervous system regulation at two months and at six months

  • change in biological stress

    change from biological stress at two months and at six months

Study Arms (2)

musicotherapy

EXPERIMENTAL

daily sessions of music listening during 2 months, associated with their standard treatment,

Other: musicotherapy

waiting list

NO INTERVENTION

waiting list

Interventions

receptive music therapy. The musical style of the session was chosen by the patient. The validated 'U' technique was employed.

musicotherapy

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • PTSD

You may not qualify if:

  • neurological diseases
  • addiction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marion TROUSSELARD

Paris, IDF, 75013, France

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: musicotherapy versus waiting list
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

May 8, 2019

First Posted

June 18, 2019

Study Start

February 1, 2020

Primary Completion

February 1, 2020

Study Completion

July 1, 2022

Last Updated

August 4, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations